• 
• See all for Dividend.com
• View Print Version

• Best Dividend Stocks
• High-Yield Dividend Stocks
• Ex-Dividend Calendar

• JNJ 76% Rate It

Diversified healthcare giant Johnson & Johnson ( JNJ ) on Wednesday caught a big upgrade from analysts at Raymond James.

The firm said it boosted its rating on JNJ from "Market Perform" to "Outperform." The move comes following J&J's announcement late Tuesday that its proposed $19.7 billion cash/stock acquisition of Swiss medical device maker Synthes has received regulatory approval.

In pursuant to the deal, J&J's Janssen unit will begin repurchasing up to $12.9 billion of JNJ's common stock.

Johnson & Johnson shares rose $1.32, or +2.1%, in premarket trading Wednesday.

The Bottom Line
We began recommending shares of Johnson & Johnson ( JNJ ) on Apr.27, when the stock was trading at $64.75. The company has a 3.87% dividend yield, based on last night's closing stock price of $63.08.

Johnson & Johnson ( JNJ ) is a "Recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Related Stocks Articles

• 
  CFO at Duke Realty Resigns, Joins JLL - Analyst Blog
  5/17/2013 05:28 PM
• 
  Pitney to Divest Management Biz - Analyst Blog
  5/17/2013 05:27 PM
• 
  Strange Business: Communists Protest Outside Barbie's Dreamhouse
  5/17/2013 04:53 PM